Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. - sprookjes - yvandenbroek - TriplyDB

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

http://www.wikidata.org/entity/Q33927147

about

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.Bacteriocins: Novel Solutions to Age Old Spore-Related Problems?Fecal microbiota transplantation: in perspective Alternatives to Antibiotics to Prevent Necrotic Enteritis in Broiler Chickens: A Microbiologist's Perspective Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection Interactions Between the Gastrointestinal Microbiome and Clostridium difficile Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes The 3D solution structure of thurincin H, a bacteriocin with four sulfur to α-carbon crosslinks Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2 Advances in the Microbiome: Applications to Clostridium difficile Infection Bacteriocin production: a relatively unharnessed probiotic trait?Bacteriocins of lactic acid bacteria: extending the family Gut bacteria in health and disease Protective role of gut commensal microbes against intestinal infections A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection [Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia].Bacteriocin Gene-Trait matching across the complete Lactobacillus Pan-genome.Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters.Bacteriocin production: a probiotic trait?Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins.Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.Microbiota-mediated colonization resistance against intestinal pathogens.Biochemical and Spectroscopic Characterization of a Radical S-Adenosyl-L-methionine Enzyme Involved in the Formation of a Peptide Thioether Cross-Link.Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes.Colonization resistance and microbial ecophysiology: using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.The Bacillus cereus group is an excellent reservoir of novel lanthipeptides.Harvesting the biological potential of the human gut microbiome.Biological systems discovery in silico: radical S-adenosylmethionine protein families and their target peptides for posttranslational modification Beneficial modulation of the gut microbiota.The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?Role of microbiota and innate immunity in recurrent Clostridium difficile infection.Compositional dynamics of the human intestinal microbiota with aging: implications for health.Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria.Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius.

P2860

Q24632558-89AC8AD8-AD9A-4D5D-A2AD-965F28A23595 Q26752537-0A66A515-1F0D-490A-9E1F-F87B1B20D6BC Q26765214-A3657135-5CAB-49E6-90F4-265D731C522A Q26773141-8A29DCAE-827A-4D07-92DD-85067253EB3B Q26776155-9FACAFDA-8BB9-47BF-8074-5D6593DC4A0A Q26778722-7F7A461A-21ED-4CB5-AA86-716DF17EEEE0 Q26995945-471CE1CF-A9B9-4477-869C-C4F5798F2A36 Q27000963-3C62DFBD-41AB-416B-BE80-979BE7A12C9E Q27670988-5CBBA7F3-1A2D-4665-ADBF-9D8AA4C3D605 Q27682707-B89D673F-5837-4B8C-BC35-1F51FB69B4A7 Q28066362-D3921D73-3D40-4B8F-B7C8-C327CB2D01C8 Q28073604-E8521F40-9E8A-446A-B920-F4A53CB073FB Q28074011-4EE95A5E-AC68-42A0-AE99-A8B8A0C0307F Q28238138-D4186B41-5C9A-44D1-90B1-A051AF47D7AF Q28253077-4694AEEC-A722-471F-95D4-2750CBF5A438 Q30240264-DAB49632-6CF9-4639-87BE-24D50C43FF7F Q33415155-59B68FD3-1032-4320-BEE2-405AB0001E67 Q33799465-924AF253-6600-45D2-83C9-8171234AA466 Q33958897-25EB1603-F39F-429C-AA8E-0DE1DD51D6F6 Q33961416-5B6AA8CB-3782-45D3-B2D1-7906F08D4659 Q34061875-F99FEA4B-1FED-414B-896D-53BFF2A85FA9 Q34097514-2D3309CC-BDEB-4510-8155-FD70B7C7E949 Q34160031-5163B27D-785A-49F1-9A2E-0E0FA0948251 Q34312732-21DCC90F-9187-4378-BC9F-2129228AF0BF Q34324937-9BC6B2BC-C098-4768-BAAA-8A8CFE9914BE Q34519519-18F09D39-4DA7-4C5E-9C9B-3123E0D8318B Q34662533-C76F4EA6-46FD-4ABD-A908-C43AFCBB5B25 Q34714359-B239FBFE-7BA4-4FD9-AF81-608C2FE17D93 Q35044119-BA6CDF6E-1116-4B83-8A29-4E7F716F1CB6 Q35075125-71314B11-4E2A-4A4F-9E69-975668ED9D7D Q35093434-FFDCCCE8-9B81-43A7-965C-32BC25FA5A23 Q35096063-78FBBE77-BDD0-4C3E-AD05-CEF0A54747AB Q35134825-422F3193-CF01-4270-8900-247CC0E2A149 Q35156014-998724AF-723B-4024-B393-B0F3BDF490EF Q35163017-37200E60-4116-4618-9807-64A81B608174 Q35195891-738E80E7-712E-4855-819C-6EE0487F4E61 Q35201232-9FA1C919-E858-4E9C-BEC2-16B7FCF0D645 Q35412870-39F2C642-5B5A-4969-9651-A80DEF9B79EA Q35433857-C46F7C56-9DC7-4697-B941-0FC939080BA9 Q35598605-55766206-E2DC-4C6D-B4BE-84B4805A9DBB

P2860

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

http://www.wikidata.org/entity/Q33927147

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Thuricin CD, a posttranslation ...... against Clostridium difficile.

@ast

Thuricin CD, a posttranslation ...... against Clostridium difficile.

@en

type

label

Thuricin CD, a posttranslation ...... against Clostridium difficile.

@ast

Thuricin CD, a posttranslation ...... against Clostridium difficile.

@en

prefLabel

Thuricin CD, a posttranslation ...... against Clostridium difficile.

@ast

Thuricin CD, a posttranslation ...... against Clostridium difficile.

@en

P1433

Q33927147-676CE361-2A78-4238-B842-EADFC0363DDA

P1476

Q33927147-AD428657-A6FC-453C-906C-A3F42A09EB47

P2093

Q33927147-23CB3DA0-D977-4D6A-BB62-205CD6EFE09E

Q33927147-2CE253E0-A0C6-4AA6-8B48-5C6F62291D6E

Q33927147-3CA49564-309B-4067-A4A0-1C56FF5E2AB7

Q33927147-5CA96625-E64D-4309-9883-E1EE1431BF06

Q33927147-B3B1E5D4-98F4-4300-B034-99F89D7C1E32

P2860

Q33927147-04F81CE8-1826-4A35-BE47-16912F1B6900

Q33927147-0F21A827-5160-4EB7-83DD-99983F7E55B0

Q33927147-1FD18BF5-A5F8-471C-8677-708919902E12

Q33927147-3CA4778A-E6CA-4970-B3D7-A3477DE7975D

Q33927147-3FEA9634-681A-438E-8C04-24EA30AB6967

Q33927147-459F3BFE-A4C9-45F8-8522-DE9614216B9B

Q33927147-5D0D44FB-D4D7-4C7E-8810-E89E002D1B62

Q33927147-5D2212BA-7582-4244-B1D4-2E7AEAD450A6

Q33927147-6F50BC93-AFCB-47F9-A2FF-F2A75D40F2DF

Q33927147-758CEA22-81DB-465E-A363-09F4F78ADB25

P304

Q33927147-D6AFE0D4-55F0-4308-9F2E-47185F131767

P31

Q33927147-E9F87A02-5D1B-4E15-829E-30ADE0EF8BE0

P356

Q33927147-FAED1A91-0322-468B-985D-D69873F05F51

P407

Q33927147-0E23A47C-B0F5-4279-8C99-A50F6C7AB207

P433

Q33927147-037E7B68-474C-4B0B-B602-247C0D1ED350

P478

Q33927147-FD80F975-8B5C-41F4-9369-07C7CFADBF13

P50

Q33927147-683F685F-356D-476B-A599-217E7EB4FACB

Q33927147-79BDE841-02F1-44F5-8E22-048330D942EB

Q33927147-A3D37B0F-6148-44B1-B599-8610A573A4B0

Q33927147-EDC73AAE-8029-4C37-91F6-85BC38E11DE6

P577

Q33927147-34EB1501-3672-4C70-9DFB-B89FAE09C89B

P5875

Q33927147-4CF8D888-E636-4F6E-9966-7DEFCD5D6F67

P698

Q33927147-B15F2AB6-B88C-497E-8FB5-0752DCA35BEA

P921

Q33927147-45F2866D-5ED6-4263-99B2-CD3C106197A2

P932

Q33927147-27C76AD3-AFF7-40B5-910C-0FE35576F544

P356

PNAS.0913554107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Thuricin CD, a posttranslation ...... against Clostridium difficile

@en

P2093

Clarissa S Sit

http://www.w3.org/2001/XMLSchema#string

Evelyn Clayton

http://www.w3.org/2001/XMLSchema#string

Jing Zheng

http://www.w3.org/2001/XMLSchema#string

Paula M O'Connor

http://www.w3.org/2001/XMLSchema#string

Randy M Whittal

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations within the first LSGGQ motif of Ste6p cause defects in a-factor transport and mating in Saccharomyces cerevisiae.

Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives

1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

Mutational analysis of the sbo-alb locus of Bacillus subtilis: identification of genes required for subtilosin production and immunity.

Lantibiotics: structure, biosynthesis and mode of action.

Molecular and genetic characterization of propionicin F, a bacteriocin from Propionibacterium freudenreichii.

Bacteriocins: developing innate immunity for food.

ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains.

Narrative review: the new epidemic of Clostridium difficile-associated enteric disease.

P304

9352-9357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0913554107

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

John Christopher Vederas

Reynolds Paul Ross

P577

2010-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43534906

http://www.w3.org/2001/XMLSchema#string

P698

20435915

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

2889069

http://www.w3.org/2001/XMLSchema#string